Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 113

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1
Chunk 113
---
 greater than ten percent beneficial
stockholders are required by Commission regulations to furnish us with copies of all Section 16(a) forms they file. To the best of the
Company’s knowledge based solely on a review of Forms 3, 4, and 5 (and any amendments thereof) received by us during or with respect
to the year ended March 31, 2025 and written representations that no other reports were required, there were no late Section 16 filings
during the year ended March 31, 2025.

ITEM 11. EXECUTIVE COMPENSATION

We are a “smaller reporting
company” under Item 10 of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the following compensation disclosure is intended to comply with the requirements applicable to smaller reporting companies.
Although the rules allow us to provide less detail about our executive compensation program, the Compensation Committee of our Board of
Directors (the “Compensation Committee”) is committed to providing the information necessary to help stockholders understand
its executive compensation-related decisions. Accordingly, this section includes supplemental narratives that describe the 2024 fiscal
year executive compensation program for our named executive officers.

 66 

Our named executive officers for the fiscal year
ended March 31, 2025, consist of our Chief Executive Officer, who also serves as our Principal Financial Officer; our Chief Medical Officer;
and our former Senior Vice President, Chief Operating Officer, who served during the fiscal year but was no longer employed as of year-end.
These individuals represented our principal executive officers and the two most highly compensated executive officers other than our principal
executive officers.

    ·
    James B. Frakes, our Chief Executive Officer and Chief Financial Officer;

    ·
    Steven P. LaRosa, M.D., our Chief Medical Officer; and

    ·
    Guy F. Cipriani, our former Senior Vice President, Chief Operating Officer.

SUMMARY COMPENSATION TABLE FOR 2025 AND 2024 FISCAL
YEARS

The following table summarizes
all compensation earned by our named executive officers for the fiscal years ended March 31, 2025 and 2024.

    Named And Principal Position 
    Fiscal Year  Ended  March 31,  
    Salary ($)  
    All Other  Compensation ($)  
    Total  ($) 
  
    James B. Frakes 
     2025